← Back to Search

Nurse-Led Palliative Care for COPD

N/A

Recruiting

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3 months, 6 months

Awards & highlights

Study Summary

This trial is testing a new way to provide palliative care to people with COPD before the end of life.

Who is the study for?

This trial is for older adults over 60 with moderate to very severe COPD, confirmed by spirometry tests. Participants must speak English and have a care partner willing to join the study. They should experience severe breathlessness or have had a hospitalization in the past year but not within the last 30 days, or be on supplemental oxygen. People with recent hospitalizations, certain cognitive impairments, advanced cancers, active major psychiatric disorders or substance abuse issues, other primary lung diseases, or non-correctable hearing impairment cannot participate.Check my eligibility

What is being tested?

The EPIC pilot RCT is testing an early palliative care intervention called EPIC for older adults with COPD and their care partners against usual COPD care alone. The intervention involves nurse coaches delivering a curriculum via phone sessions followed by monthly follow-ups to improve quality of life and reduce healthcare utilization.See study design

What are the potential side effects?

Since this trial focuses on palliative education and support rather than medication, traditional side effects are not expected. However, participants may experience emotional discomfort when discussing sensitive topics related to their illness during coaching sessions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3 months, 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3 months, 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months, 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability (Qualitative)

Acceptability (Quantitative)

Intervention Feasibility

+1 more

Secondary outcome measures

Chronic Respiratory Questionnaire (CRQ)

De Jon Gierveld Loneliness Scale

Healthcare and palliative care utilization

+7 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention (EPIC plus Usual COPD Care)Experimental Treatment1 Intervention

Participants randomized to this arm will receive the experimental treatment for COPD (i.e. EPIC plus usual COPD care).

Group II: Usual COPD CareActive Control1 Intervention

Participants randomized to this arm will receive the standard of care for COPD.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor

1,588 Previous Clinical Trials

2,280,192 Total Patients Enrolled

Media Library

EPIC Clinical Trial Eligibility Overview. Trial Name: NCT05040386 — N/A

Chronic Obstructive Pulmonary Disease Research Study Groups: Usual COPD Care, Intervention (EPIC plus Usual COPD Care)

Chronic Obstructive Pulmonary Disease Clinical Trial 2023: EPIC Highlights & Side Effects. Trial Name: NCT05040386 — N/A

EPIC 2023 Treatment Timeline for Medical Study. Trial Name: NCT05040386 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available for participation in this research?

"Affirmative. According to clinicaltrials.gov, the trial which was first published on May 19th 2022 is currently taking applications for its study pool. They are looking for 120 individuals to be enrolled from a single location."

Answered by AI

What is the ultimate aim of this clinical research?

"The principal outcome of this investigation, which will be measured from the start to 6 months, is Acceptability (Quantitatively). Secondary aims include UAB Life Space Assessment (LSA) - 15 questions that evaluate a person's physical mobility and its correlation with social isolation. The threshold score for restricting life-space mobility is 60 or higher; lower scores indicate greater restriction. Additionally, we have observed that restricted life-space can lead to COPD exacerbations. MCID=5 points & alpha=0.80., Chronic Respiratory Questionnaire (CRQ) - 20 queries related to dyspnea, fatigue, emotional well-"

Answered by AI

How many participants are currently part of this research endeavor?

"Affirmative. Clinicaltrials.gov hosts data indicating that this clinical trial, which first appeared on May 19th 2022, is actively recruiting candidates. The study hopes to enroll 120 people at a single medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Nurse Coach-Led Early Palliative Care for Older Adults With COPD and Their Care Partners: The Project EPIC Pilot RCT

Anand Iyer 2022. "Nurse Coach-Led Early Palliative Care for Older Adults With COPD and Their Care Partners: The Project EPIC Pilot RCT". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05040386.

All > Copd